10000+
1000+
178
134
13196
Cat. No. | Product Name | ||
---|---|---|---|
L6800 | 中国药典收录天然产物库 | 2051 compounds | |
2051 种中国药典收录的天然产物,是药物开发、药理研究等领域的有力工具; | |||
L3300 | 组胺&褪黑色素化合物库 | 153 compounds | |
153 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L6810 | 中药单体化合物库 | 2755 compounds | |
2755 种中药来源的单体化合物,是药物开发、药理研究等领域的有力工具; | |||
L2600 | 神经信号分子库 | 2540 compounds | |
2540 种CNS 相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L6001 | Mini真菌代谢天然产物筛选库 | Inquiry | |
L6230 | 苗药化合物库 | 534 compounds | |
534种苗族特色药材的天然产物分子,可用于高通量和高内涵筛选 | |||
L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
高溶解度共价杂环片段库中的 369 个化合物 | |||
L2200 | 酪氨酸激酶分子库 | 1016 compounds | |
1016 种酪氨酸激酶抑制剂的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2550 | 谷氨酰胺代谢化合物库 | 565 compounds | |
565 种谷氨酰胺代谢相关的分子,可以用于高通量和高内涵筛选; | |||
L9411 | 半胱氨酸共价化合物库 | 70 compounds | |
半胱氨酸共价库包含 70 个化合物。 | |||
L2300 | 离子通道库 | 931 compounds | |
931 种与离子通道相关的生物活性小分子化合物的特有集合,用于离子通道相关的疾病和药物研究,可用于高通量筛选和高内涵筛选; | |||
L3800 | NF-κB 通路分子库 | 729 compounds | |
729 个 NF-κB 信号通路相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L9900 | 药用辅料化合物库 | 182 compounds | |
182 种 FDA 批准药品中的非活性成分集合 | |||
L1310 | 细胞骨架化合物库 | 759 compounds | |
759 种细胞骨架相关的化合物,可以用于高通量和高内涵筛选; | |||
L1400 | MAPK 抑制剂库 | 365 compounds | |
365 种与MAPK 信号通路相关的生物活性小分子化合物的特有集合,可用于高通量筛选和高内涵筛选; | |||
L8600 | 泛素化化合物库 | 210 compounds | |
210 种泛素化相关的小分子,用于高通量和高内涵筛选; | |||
L3410 | 临床前化合物库 | 701 compounds | |
701 种临床前小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L1600 | 激酶抑制剂库 | 2720 compounds | |
2720 种激酶抑制剂/调节剂的独特集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L4700 | 免疫/炎症分子化合物库 | 4720 compounds | |
4720 种具有抗炎症活性的化合物的特有集合,可用于高通量筛选和高内涵筛选; | |||
L5510 | 肝脏毒性化合物库 | 1001 compounds | |
1001 个肝脏毒性化合物的特有集合,可用于高通量、高内涵筛选,是毒理学研究的良好工具; | |||
L6710 | 中药抗炎分子库 | 1246 compounds | |
1246 种具有抗炎活性或靶向炎症相关靶点的中药单体集合,是药物开发、药理研究的有效工具; | |||
L8500 | HIF-1化合物库 | 1336 compounds | |
1336 个HIF-1相关小分子的独特集合,可用于缺血性疾病、癌症等相关领域的药物开发和药理研究; | |||
L9500 | 表型筛选靶点鉴定库 | 1796 compounds | |
1796 种靶点明确的已知活性化合物,适合表型筛选; | |||
L2800 | 5-羟色胺分子库 | 268 compounds | |
268 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L8300 | 染色质修饰分子库 | 250 compounds | |
250 种染色质化学修饰相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L7600 | 趋化因子抑制剂库 | 59 compounds | |
59 种趋化因子或其受体抑制剂的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2400 | 内分泌激素分子库 | 784 compounds | |
784 种与内分泌系统相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L3600 | 细胞因子抑制剂库 | 604 compounds | |
604 个与细胞因子紧密相关的化合物集合,是高通量、高内涵筛选的良好载体; | |||
L2000 | 抑制剂库 | 8328 compounds | |
8328 个小分子抑制剂的独特集合,主要用于细胞信号研究、新药筛选、高通量筛选和高内涵筛选; | |||
L6610 | 抗感染天然产物库 | 1060 compounds | |
1060 个抗感染相关的天然产物集合,是药物开发、药理研究的有效工具; | |||
L2120 | 抗癌临床化合物库 | 2545 compounds | |
2545 个具有抗癌活性小分子的独特集合,可用于高通量高内涵筛选。 | |||
L9830 | 抗帕金森病化合物库 | 857 compounds | |
857 种帕金森病相关的化合物集合,可用于高通量和高内涵筛选; | |||
L5600 | Mini骨架库 | 5000 compounds | |
多样性好,从一百多万个小分子中挑选而出,5000 个化合物代表5000 种骨架结构; | |||
L6210 | 藏药化合物库 | 747 compounds | |
747 种藏药来源的天然产物分子集合,可以用于高通量和高内涵筛选; | |||
L4020 | NO PAINS 化合物库 | 9384 compounds | |
TargetMol NO PAINS 化合物库包含 9384 个剔除了PAINS 的小分子活性化合物,可用于新药研发,信号通路研究,老药新用等研究。 | |||
L4710 | 非甾体类抗炎化合物库 | 530 compounds | |
530 种非甾体类的抗炎相关化合物,可用于高通量和高内涵筛选; | |||
L6720 | 抗COVID-19中药单体库 | 1147 compounds | |
根据抗新冠肺炎疫情过程中应用于临床治疗的中药方剂,收集了1147 种相关中药来源的单体化合物,可用于高通量和高内涵筛选,是抗新冠病毒药物研发的良好工具; | |||
L1610 | FDA 上市激酶抑制剂库 | 263 compounds | |
263种靶向激酶的上市药物集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L6750 | 活血化瘀中药单体库 | 580 compounds | |
580种来源于常见活血化瘀中药的单体化合物,是药物开发、药理研究等领域的有效工具。 | |||
L1100 | 蛋白酶抑制剂库 | 343 compounds | |
343 种已知的小分子蛋白酶抑制剂的特有集合,可用于高通量筛选和高内涵筛选; | |||
L9410 | 共价抑制剂库 | 1920 compounds | |
1920 种小分子的独特集合,包含已发现的共价抑制剂以及包含某些共价反应基团常见弹头的分子,如氯乙酰基,2-氯丙酰基,丙烯酰基,1-丙-2-炔基,1-丁-2-炔基,酮羰基,二硫键等,可以用于共价抑制剂药物研发; | |||
L2010 | 高选择性抑制剂库 | 575 compounds | |
575种具有高选择性的抑制剂集合 | |||
L8110 | 细胞重编程化合物库 | 1813 compounds | |
1813 种重编程信号通路相关的生物活性小分子化合物的特有集合,可用于高通量、高内涵筛选 | |||
L1800 | 抗感染化合物库 | 2938 compounds | |
2938 种具有抗感染活性的化合物的特有集合,包括抗细菌、抗真菌、抗巨细胞病毒、抗HIV、抗SARS、抗流感等活性; | |||
L6220 | 蒙药化合物库 | 950 compounds | |
950 种蒙药来源的天然产物分子集合,可以用于高通量和高内涵筛选; | |||
L6300 | 药食同源库 | 1290 compounds | |
1290 个药食同源化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L9200 | 药物功能重定位化合物库 | 4630 compounds | |
4630 种全球上市药物和临床药物的独特集合,可用于高通量筛选和高内涵筛选,是老药新用、新的药物靶点筛选和细胞诱导的有效工具。 | |||
L8200 | 抗衰老化合物库 | 3279 compounds | |
3279 个抗衰老化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L6730 | 抗病毒中药单体化合物库 | 268 compounds | |
268 种具有抗病毒活性的中药单体集合,是药物开发、药理研究的有效工具; | |||
L3400 | 临床期小分子药物库 | 3404 compounds | |
3404 个临床期化合物集合,可用于高通量筛选和高内涵筛选; | |||
L6740 | 抗结直肠癌中药单体化合物库 | 382 compounds | |
382 种抗结直肠癌相关的中药单体集合,是药物开发、药理研究的有效工具; | |||
L6200 | 瑶药化合物库 | 221 compounds | |
221 种瑶药来源的天然产物分子集合,可以用于高通量和高内涵筛选; | |||
L6400 | 海洋天然产物库 | 144 compounds | |
144 种海洋来源的单体化合物,是药物开发、药理研究等领域的有力工具; | |||
L9400 | PPI抑制剂库 | 485 compounds | |
485 种已知活性的 PPI 相关的抑制剂,可用于高通量、高内涵筛选; | |||
L9100 | 磷酸酶抑制剂化合物库 | 79 compounds | |
79 种已知活性的磷酸酶抑制剂的集合,可用于化合物筛选、化学基因组学、药理分析等方面; | |||
L1520 | 膜蛋白靶向化合物库 | 4175 compounds | |
L7000 | 活性脂质化合物库 | 385 compounds | |
385 种生物活性小分子化合物,用于高通量、高内涵筛选; | |||
L1000 | 上市药物库 | 2808 compounds | |
2808 个上市药物化合物集合,可用于高通量筛选和高内涵筛选; | |||
L1380 | 转录因子库 | 695 compounds | |
695 种转录因子靶向、结构新颖的化合物; | |||
L1200 | 表观遗传库 | 953 compounds | |
953 种表观遗传学研究相关的生物活性小分子的特有集合,用于表观遗传学研究及其相关的检测和高通量、高内涵筛选; | |||
L2501 | 人内源代谢化合物库 Plus | 1283 compounds | |
1283种内源性生物活性化合物的独特集合,用于高通量、高内涵筛选。 | |||
L1500 | GPCR靶点分子库 | 1940 compounds | |
1940 种与 G 蛋白及其耦联受体相关的生物活性小分子化合物,所有小分子都具有良好的生物和药理活性,部分是 FDA 批准的上市药物; | |||
L9600 | 多肽分子库 | 791 compounds | |
791 种多肽类分子,可用于多肽药物开发及信号转导通路和作用机制研究; | |||
L1580 | GPCR库Plus | 338 compounds | |
338 种GPCR 靶向、结构新颖的化合物; | |||
L1300 | PI3K/Akt/mTOR 化合物库 | 420 compounds | |
420 种与PI3K/Akt/mTOR 相关的生物活性小分子化合物的特有集合,用于PI3K/Akt/mTOR 相关研究以及高通量、高内涵筛选; | |||
L2192 | 抗胰腺癌化合物库 | 2238 compounds | |
2238 种与胰腺癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L9700 | 内质网应激化合物库 | 193 compounds | |
193 个内质网应激相关的化合物集合,可用于高通量和高内涵筛选; | |||
L1120 | AMPK靶向分子库 | 80 compounds | |
80 个靶向AMPK 的分子集合,可用于高通量和高内涵筛选; | |||
L6140 | 糖类及苷类化合物库 | 362 compounds | |
362 种糖类或苷类的化合物,可用于高通量筛选和高内涵筛选; | |||
L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
高溶解性卤化片段库包含796 个卤化片段化合物。 | |||
L4800 | 血管生成库 | 1353 compounds | |
1353 个高潜力的抑制或促进血管生成的小分子集合,可用于药物靶点开发、血管生成机理研究的高通量筛选,高内涵筛选; | |||
L2140 | 癌细胞分化化合物库 | 406 compounds | |
406 个诱导肿瘤细胞分化化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2500 | 人内源代谢化合物库 | 499 compounds | |
499 种内源性生物活性化合物的独特集合,用于高通量、高内涵筛选; | |||
L2520 | 糖代谢化合物库 | 702 compounds | |
702 种糖代谢相关的化合物,可用于高通量和高内涵筛选; | |||
L2610 | 神经递质受体化合物库 | 1513 compounds | |
1513 种与神经递质受体相关的化合物,用于高通量、高内涵筛选; | |||
L7700 | 神经再生化合物库 | 524 compounds | |
524 种神经再生相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L5300 | 线粒体靶向库 | 812 compounds | |
812 种具有潜在或确定线粒体靶向活性的化合物,以促进针对线粒体的药物研究; | |||
L4660 | 神经疾病库Plus | 1246 compounds | |
1246 种神经系统相关、结构新颖的化合物; | |||
L9820 | β-内酰胺类化合物库 | 97 compounds | |
97 种β-内酰胺类化合物的集合,可以用于高通量和高内涵筛选; | |||
L2900 | 氧化还原化合物库 | 1264 compounds | |
1264 个活性化合物,已经验证具有一定的抗氧化活性,包括 ROS 清除剂、iNOS、eNOS、及抗氧化的天然产物,是研究疾病机理以及药物研究的优良载体 | |||
L7100 | 抗肥胖化合物库 | 2247 compounds | |
2247 个抗肥胖化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L9000 | 细胞凋亡化合物库 | 1760 compounds | |
1760 种与凋亡相关的生物活性小分子化合物的特有集合,多用于研究肿瘤发生发展机制和抗癌药物筛选等。可用于高通量筛选和高内涵筛选; | |||
L3900 | DNA 损伤和修复分子库 | 910 compounds | |
910 个与 DNA 损伤和修复紧密相关的化合物集合,是高通量筛选,高内涵筛选的良好载体; | |||
L9420 | 外泌体相关化合物库 | 76 compounds | |
76 种外泌体相关的化合物,可以用于高通量和高内涵筛选; | |||
L2510 | 脂代谢化合物库 | 492 compounds | |
492 个脂代谢相关的化合物集合,可用于高通量和高内涵筛选; | |||
L2910 | 抗氧化化合物库 | 1314 compounds | |
氧化应激(Oxidative Stress,OS)是指体内氧化与抗氧化作用失衡的一种状态。氧化应激导致活性氧(ROS)大量积累,氧化程度超出抗氧化物的清除能力,从而引起氧化损伤,氧化应激损伤是许多疾病发生的基础,不同程度的氧化应激造成的细胞效应与心脑血管疾病、神经退行性病变、炎症和肿瘤密切相关。抗氧化剂是一类能够对抗氧化应激,降低氧化损伤的一类化合物。 TargetMol 抗氧化化合物库是1314 种对氧化应激具有抑制作用的小分子特有集合,是研究氧化应激的有用工具,可以用于高通量筛选和高内涵筛选。 | |||
L5200 | 抗代谢疾病化合物库 | 1544 compounds | |
1544 个代谢疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L7300 | 钾通道分子库 | 152 compounds | |
152 种钾通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2191 | 抗乳腺癌化合物库 | 1939 compounds | |
1939 种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; | |||
L3700 | JAK-STAT 化合物库 | 252 compounds | |
252 个 JAK/STAT 靶点相关的小分子化合物的独特集合,用于高通量、高内涵筛选; | |||
L6600 | 胃肠炎天然产物库 | 219 compounds | |
219 种胃肠炎相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2570 | 人代谢物化合物库 | 4454 compounds | |
4454 种人代谢物的独特集合,用于高通量、高内涵筛选; | |||
L1110 | 微管靶向化合物库 | 142 compounds | |
142 种靶向微管的分子集合,用于高通量筛选和高内涵筛选; | |||
L3980 | DNA损伤/修复库Plus | 667 compounds | |
667 种 DNA 损伤/修复靶向、结构新颖的化合物; | |||
L4900 | 心血管毒性化合物库 | 131 compounds | |
131 种心血管毒性化合物的独特集合,可用于毒理学研究; | |||
L5100 | 含氟化合物库 | 574 compounds | |
574 个含氟化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2540 | 肠道微生物代谢化合物库 | 614 compounds | |
614 种肠道微生物代谢物的集合,可以用于高通量和高内涵筛选; | |||
L6030 | 天然产物衍生物虚筛化合物库 | 163000 compounds | |
16.3万种天然产物衍生物,并且在持续增加中; | |||
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 237 compounds | |
237 个Wnt & Hedgehog & Notch 靶点相关的生物活性小分子化合物的特有集合,用于相关通路的研究及药物的筛选,可用于高通量、高内涵筛选。 | |||
L6150 | 天然产物共价化合物库 | 583 compounds | |
提供产品的生物学信息和药物学信息,为筛选提供理论方向和研究基础; | |||
L9860 | 抗抑郁症化合物库 | 1163 compounds | |
1163 种与抑郁症相关的化合物,可以用于高通量和高内涵筛选 | |||
L5500 | 毒性化合物库 | 262 compounds | |
262 个细胞毒性化合物的特有集合,可用于高通量、高内涵筛选。 | |||
L7900 | 成骨分子库 | 317 compounds | |
317 种成骨相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L9810 | 抗纤维化化合物库 | 1180 compounds | |
1180 种潜在的抗纤维化分子,是研究纤维化的有效工具,可以用于高通量筛选和高内涵筛选; | |||
L3200 | 自噬库 | 1248 compounds | |
1248 种细胞自噬相关的生物活性小分子化合物的特有集合,用于自噬相关的研究,用于高通量、高内涵筛选; | |||
L4500 | 抗真菌库 | 252 compounds | |
252 个抗真菌活性化合物的独特集合,包含作用于真菌相关靶点的化合物和临床中用于真菌类疾病的药物,是相关疾病药物筛选的有效工具。 | |||
L4000 | 经典已知活性库 | 14439 compounds | |
14439 个已知活性化合物的集合,可用于高通量筛选、高内涵筛选、细胞诱导和靶点确认; | |||
L2521 | 糖酵解化合物库 | 555 compounds | |
555 种糖酵解相关的活性化合物,可用于高通量和高内涵筛选 | |||
L8800 | 药物片段库 | 1119 compounds | |
1119 种药物片段分子,是FBDD 方法新药筛选的有力工具; | |||
L2195 | 抗前列腺癌化合物库 | 2070 compounds | |
2070 种与前列腺癌相关的化合物,可以用于高通量和高内涵筛选 | |||
L4200 | FDA 上市药物库 | 1729 compounds | |
1729 个FDA 批准药物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L6820 | 烟草单体化合物库 | 747 compounds | |
747种烟草单体化合物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L5700 | 精选片段库 | 246 compounds | |
246 个片段小分子的独特集合,可用于基于片段的筛选和药物发现(FBDD); | |||
L2190 | 抗肺癌化合物库 | 1702 compounds | |
1702 种与肺癌相关的化合物,可以用于抗肺癌药物研发和药理研究; | |||
L6010 | 天然产物库 | 3840 compounds | |
3840 种天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L9610 | 环肽库 | 55 compounds | |
55 种环肽分子,可用于高通量和高内涵筛选; | |||
L7200 | 钙通道分子库 | 140 compounds | |
140 种钙通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L4010 | 已知活性化合物库 | 22555 compounds | |
22555 个已知活性化合物的集合,可用于高通量筛选、高内涵筛选、细胞诱导和靶点确认; | |||
L2130 | 抗癌细胞代谢库 | 1268 compounds | |
1268 种癌细胞代谢相关的生物活性小分子化合物的特有集合,用于肿瘤相关的研究以及抗肿瘤药物的筛选,用于高通量、高内涵筛选; | |||
L2150 | 抗癌药物库 | 3080 compounds | |
3080 个具有抗癌活性小分子的独特集合,生物活性已经临床前实验证实,可用于高通量、高内涵筛选; | |||
L8400 | 血液病分子库 | 514 compounds | |
514 种造血系统疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2560 | 代谢化合物库 | 2320 compounds | |
2320 种代谢途径相关的化合物,可用于高通量和高内涵筛选。 | |||
L6020 | 天然产物单体化合物库 | 16627 compounds | |
16627 种精选天然产物集合,结构多样,遍布多种动植物与微生物; | |||
L8700 | 铁死亡化合物库 | 779 compounds | |
779 种与铁死亡通路相关的化合物,可用于高通量和高内涵筛选; | |||
L8100 | 细胞周期化合物库 | 677 compounds | |
677 种细胞周期相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2170 | 肿瘤免疫治疗小分子化合物库 | 449 compounds | |
449 种靶向肿瘤免疫治疗靶点的小分子,可用于高通量和高内涵筛选,是研究肿瘤免疫治疗的有力工具; | |||
L6500 | 微生物天然产物库 | 550 compounds | |
550 种微生物来源的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2110 | 抗癌上市药物库 | 1779 compounds | |
1779 个具有抗癌活性小分子的独特集合,所有化合物都经过了严格的临床前研究和临床试验,由FDA、EMA 或NMPA 批准上市,可用于高通量、高内涵筛选。 | |||
L4100 | TGF-β/Smad靶点化合物库 | 184 compounds | |
184 个 TGF-β/Smad 靶点相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L6000 | 高通量筛选天然产物库 | 4533 compounds | |
4533 种天然产物的独特集合,是药物开发、药理研究、干细胞分化、指纹图谱研究、质量研究等领域的有力工具,可用于HTS 和HCS; | |||
L2630 | 神经元分化化合物库 | 672 compounds | |
672 种与神经元分化相关的化合物,可以用于神经系统疾病药物研发 | |||
L6110 | 生物碱类天然产物库 | 464 compounds | |
464 种生物碱类天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L1720 | 核苷类化合物库 | 334 compounds | |
334 种核苷类化合物,包括核苷酸、核苷酸类似物及衍生物等,适用于抗病毒、抗肿瘤、抗真菌、抗抑郁等药物的研发; | |||
L2180 | 抗肿瘤库Plus | 1468 compounds | |
1468 种抗肿瘤相关、结构新颖的化合物; | |||
L7500 | 凝血与抗凝化合物库 | 144 compounds | |
144 个化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L3510 | 甲基化化合物库 | 128 compounds | |
128 种甲基化相关的化合物,可以用于高通量和高内涵筛选; | |||
L9840 | 抗阿尔茨海默症化合物库 | 986 compounds | |
986 种阿尔茨海默症相关的化合物集合,可用于高通量和高内涵筛选; | |||
L6620 | 抗寄生虫天然产物库 | 253 compounds | |
253 个抗寄生虫相关的天然产物集合,是药物开发、药理研究的有效工具; | |||
L1510 | 核受体化合物库 | 531 compounds | |
531 个核受体作用化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2152 | 靶向治疗药物库 | 119 compounds | |
119 个肿瘤靶向治疗药物,可以用于高通量和高内涵筛选; | |||
L2620 | 神经退行性疾病化合物库 | 2154 compounds | |
2154 种与神经退行性疾病相关的化合物,可用于高通量和高内涵筛选; | |||
L3500 | 组蛋白修饰化合物库 | 469 compounds | |
469 个组蛋白修饰相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L5610 | Golden骨架库 | 10000 compounds | |
多样性好,从160万个小分子中挑选而出,10000 个化合物,5000种骨架结构; | |||
L4600 | 植物来源化合物库 | 3048 compounds | |
3048 个植物来源天然产物的独特集合,来自277类植物的精心之选; | |||
L1010 | FDA上市及药典收录分子库 | 3158 compounds | |
3158 个上市及药典分子集合,可用于高通量筛选和高内涵筛选; | |||
L2160 | 抗癌活性化合物库 | 3188 compounds | |
3188 种具有抗肿瘤活性的化合物的特有集合,用于高通量、高内涵筛选; | |||
L7110 | 抗高血压化合物库 | 678 compounds | |
678 种高血压相关的小分子,用于高通量和高内涵筛选; | |||
L7850 | 高溶解性3D结构多样性片段化合物库 | 1079 compounds | |
高溶解性3D 结构多样性片段库包含1079 个化合物。 | |||
L2100 | 抗癌化合物库 | 7234 compounds | |
7234 种肿瘤相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L9230 | ReFRAME 相关化合物库 | 3210 compounds | |
3210 化合物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L5900 | 血脑屏障通透化合物库 | 509 compounds | |
509 个 CNS-Penetrant 生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8000 | 干细胞分化化合物库 | 1197 compounds | |
1197 种干细胞分化信号通路相关的生物活性小分子化合物的特有集合,可用于高通量、高内涵筛选; | |||
L2193 | 抗肝癌化合物库 | 1787 compounds | |
1787 种与肝癌相关的化合物,可以用于抗肝癌药物研发和药理研究; | |||
L7870 | 可溶性羧酸片段化合物库 | 1806 compounds | |
可溶性羧酸片段库包含 1806 个化合物 | |||
L1710 | 抗COVID-19化合物库 | 1133 compounds | |
1133 种对SARS-CoV-2有抑制作用或潜在抑制作用的化合物集合,可用于高通量和高内涵筛选; | |||
L7400 | 钠通道分子库 | 118 compounds | |
118 种钠通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2196 | 抗卵巢癌化合物库 | 1867 compounds | |
1867 种与卵巢癌相关的化合物,可以用于抗卵巢癌药物研发和药理研究 | |||
L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
高溶解性片段药效团库包含985 个片段小分子。 | |||
L8720 | 细胞焦亡化合物库 | 1066 compounds | |
1066 种细胞焦亡相关的化合物,可以用于细胞焦亡相关研究。 | |||
L1900 | 抗糖尿病库 | 683 compounds | |
683 种生物活性小分子化合物; | |||
L9300 | 大环化合物库 | 210 compounds | |
210 种活性已知的大环化合物,用于高通量、高内涵筛选; | |||
L4510 | 抗寄生虫库 | 419 compounds | |
419 种具有抗寄生虫活性的小分子化合物; | |||
NY1000 | 天然产物衍生物库 | 4000 compounds | |
22个天然产物骨架,3745个天然产物衍生物; | |||
L6120 | 黄酮类天然产物库 | 514 compounds | |
514 种黄酮类天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L6160 | Ro5类药天然产物库 | 2703 compounds | |
2703 种符合 RO5原则的天然产物单体集合,可以用于高通量和高内涵筛选; | |||
L6100 | 天然多酚类化合物库 | 635 compounds | |
635 个天然多酚化合物的独特集合,可用于高通量、高内涵筛选; | |||
L4400 | 抗生素库 | 692 compounds | |
692 个具有抗菌活性化合物的独特集合,是医药研究的优良工具库和药物筛选的有效载体; | |||
L9210 | 儿童药物库 | 972 compounds | |
972 种儿童药物的独特集合,可用于高通量筛选和高内涵筛选 | |||
L2151 | 化疗药物库 | 48 compounds | |
48 个肿瘤化疗药物,可以用于高通量和高内涵筛选; | |||
L5800 | 药物代谢杂质库 | 197 compounds | |
197 种药物异构体/代谢产物的特有集合,可用于高通量、高内涵筛选; | |||
L2194 | 抗结直肠癌化合物库 | 1545 compounds | |
1545 种与结直肠癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L9001 | 食品添加剂化合物库 | 425 compounds | |
425种食品添加剂的集合 | |||
LF1000 | 多样性核心预制库 | 50000 compounds | |
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap. | |||
L6130 | 萜类天然产物库 | 516 compounds | |
516 种萜类天然产物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L5400 | 抗心血管疾病化合物库 | 1408 compounds | |
1408 种心血管疾病相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8710 | 铜死亡化合物库 | 400 compounds | |
TargetMol 铜死亡化合物库集合了 400 种与铜死亡相关的化合物,可以用于铜死亡机制及相关疾病研究 | |||
L6700 | 抗癌天然产物库 | 1772 compounds | |
1772 种已知活性天然产物的独特集合,是肿瘤药物开发、抗癌先导化合物筛选等领域的有力工具,可用于HTS 和HCS。 | |||
L9850 | 口服活性化合物库 | 2427 compounds | |
2427 种口服活性化合物独特集合,可用于高通量筛选和高内涵筛选 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10682L |
CARM1-IN-1
CARM1-IN-7G |
Histone Methyltransferase | Chromatin/Epigenetic |
CARM1-IN-1 (CARM1-IN-7G) 是 CARM1 的选择性抑制剂,IC50 为 8.6 μM。 CARM1-IN-1 对 PRMT1 和 SET7 的活性较弱,IC50 > 600 μM。 | |||
T11332 |
FUBP1-IN-1
FUBP1–IN-1 |
Others | Others |
FUBP1 - in-1, with an IC50 value of 11.0 M, is an effective FUSE binding protein 1 (FUBP1) inhibitor that can interfere with the binding of FUBP1 to its SINGLE-strand target DNA FUSE sequence. | |||
T11025 |
hDHODH-IN-3
DHODH-IN-2 |
Dehydrogenase | Metabolism |
hDHODH-IN-3 是人二氢乳清酸脱氢酶的抑制剂,pMIC50 值为 8.6。 hDHODH-IN-3 可以抑制麻疹病毒的复制。 | |||
T11029 |
hDHODH-IN-5
DHODH-IN-7 |
Dehydrogenase | Metabolism |
hDHODH-IN-5 是人源二氢乳清酸脱氢酶的抑制剂 (hDHODH, IC50 = 0.91 μM)。 | |||
T40290 |
CDK12-IN-5
CDK12-IN-5 |
||
CDK12-IN-5 is a pyrazolotriazine compound that effectively inhibits CDK12, with an IC50 value of 23.9 nM at a high ATP concentration of 2 mM. However, CDK12-IN-5 does not exhibit inhibitory effects on CDK2/Cyclin E (IC50 = 173 μM) and CDK9/Cyclin T1 (IC50 = 127 μM) at the same high ATP concentration of 2 mM, as stated in WO2021116178A1. | |||
T39705 |
ATG7-IN-1
ATG7-IN-1 |
Autophagy | Autophagy |
ATG7-IN-1 是一种选择性 ATG7 抑制剂,IC50 为 62 nM。 | |||
T8763 |
PTGR2-IN-1
PTGR2-IN-22 |
Others | Others |
PTGR2-IN-1 是有效的 PTGR2抑制剂,IC50为 ~0.7 μM。它能够提高转染 PTGR2 的 HEK293T 细胞 15-keto-PGE2 依赖的 PPARγ 转录活性。 | |||
T40443 |
JAK2-IN-6
JAK2-IN-6 |
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK2-IN-6是一种有效的、有选择性的 JAK2抑制剂(ic50为22.86 μg/mL),是一种多取代氨基噻唑衍生物。JAK2-IN-6抑制 JAK2酶的活性 ,通过干扰与 JAK2相关的信号通路,从而对 JAK2失调的特定疾病产生治疗作用, 对 JAK1和JAK3不显示出活性。JAK2是一种参与调节细胞生长和分裂的信号通路的蛋白质。JAK2的异常激活与多种疾病有关,包括某些类型的癌症和炎症性疾病。JAK2-IN-6对癌细胞具有抗增殖活性。 | |||
T11028 |
hDHODH-IN-4
DHODH-IN-5 |
Dehydrogenase | Metabolism |
hDHODH-IN-4 (DHODH-IN-5) 是一种有效的人二氢硼酸脱氢酶 (DHODH) 抑制剂,对人重组 DHODH 的 pIC50 为 7.8。hDHODH-IN-4 抑制麻疹病毒复制,pMIC50 为 8.8。 | |||
T40109 |
APOL1-IN-1
APOL1-IN-1 |
Others | Others |
APOL1-IN-1是一种有效的载脂蛋白 L1(APOL1) 的抑制剂,可用于研究局灶节段性肾小球硬化 (FSGS) 和非糖尿病肾病 (NDKD) 的发病原理,促进对此类疾病的研究。 | |||
T9863 |
PKCiota-IN-2
PKCiota-IN-49 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
PKCiota-IN-2 (PKCiota-IN-49) 是一种有效的 PKCiota (PKC-ι) 抑制剂,IC50 为 2.8 nM。PKCiota-IN-2 还抑制 PKC-α 和 PKC-ε,IC50 分别为 71 nM 和 350 nM。 | |||
T38684 |
AKR1C3-IN-4
AKR1C3-IN-4 |
NADPH | Metabolism |
AKR1C3-IN-4 是醛酮还原酶 1C3 (AKR1C3) 选择性抑制剂,IC50为 0.56 μM。它在去势抵抗性前列腺癌中有研究的价值。 | |||
T40146 |
Sec61-IN-1
Sec61-IN-1 |
Others | Others |
Sec61-IN-1是一种有效的Sec61抑制剂。 | |||
T39764 |
ALK2-IN-4
ALK2-IN-4 |
||
ALK2-IN-4, a highly effective ALK2 inhibitor. | |||
T35899 |
JAK1-IN-8
JAK1-IN-8 |
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK1-IN-8,Janus 激酶 1 (JAK1)的特异性抑制剂(IC50<500 nM)。 | |||
T38905 |
FATP1-IN-1
FATP1-IN-1 |
Others | Others |
FATP1-IN-1 是一种强效的脂肪酸转运蛋白1(FATP1)抑制剂。它能有效抑制对FATP1功能至关重要的重组人类或小鼠的酰辅酶A合成酶活性。其抑制特征通过IC50值体现,分别为人类FATP1的0.046 μM 和小鼠FATP1的0.60 μM。 | |||
T2043 |
Mutant IDH1-IN-1
IDH1-IN-1 |
Dehydrogenase; Isocitrate Dehydrogenase (IDH) | Metabolism |
Mutant IDH1-IN-1 是 IDH1突变体的选择性抑制剂,能够作用于突变体 IDH1 R132C/R132C (IC50:4 nM) ,IDH1 R132H/R132H (IC50:42 nM) ,IDH1 R132H/WT (IC50:80 nM) 和野生型 IDH1 (IC50:143 nM)。 | |||
T11031 |
hDHODH-IN-7
DHODH-IN-9 |
Dehydrogenase | Metabolism |
hDHODH-IN-7 (DHODH-IN-9) 是一种含嗪的类似物,是一种人二氢乳清酸酯脱氢酶抑制剂。hDHODH-IN-7 具有抗病毒作用,pMIC50 为 7.4。 | |||
T40350 |
HPK1-IN-4
HPK1-IN-4 |
MAPK | MAPK |
HPK1-IN-4是一种HPK1(MAPK41)抑制剂,IC 50为0.061 nM。HPK1-IN-4常被作为临床前免疫治疗工具化合物。 | |||
T39389 |
KDM2B-IN-2
KDM2B-IN-2 |
Histone Demethylase | Chromatin/Epigenetic |
KDM2B-IN-2是一种有效的组蛋白去甲基化酶 (KDM2B) 抑制剂。 | |||
T35900 |
JAK2-IN-7
JAK2-IN-7 |
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
JAK2-IN-7 是一种选择性 JAK2抑制剂,对 JAK2,SET-2 和 Ba/F3V617F 细胞的IC50为 3、11.7 和 41 nM。 JAK2-IN-7 的选择性是 JAK1, JAK3,FLT3 的 14 倍以上。JAK2-IN-7 刺激细胞周期停滞在 G0/G1 期,并诱导肿瘤细胞凋亡 (apoptosis),具有抗肿瘤活性。 | |||
T4438 |
Porcn-IN-1
Porcupine-IN-1 |
Porcupine | Stem Cells |
Porcn-IN-1 (Porcupine-IN-1) 是一种有效的porcupine 抑制剂(IC50:0.5±0.2 nM)。 | |||
T8336 |
OGG1-IN-08
OGG1-IN-O8 |
Others | Others |
OGG1-IN-08 (OGG1-IN-O8) 是 8-氧鸟嘌呤 DNA 糖基酶-1 抑制剂(IC50:0.22 μM)。它能够减少 OGG1 的糖基化酶和裂解酶活性。 | |||
T38078 |
TLR7/8-IN-1
TLR7/8-IN-1 |
TLR | Immunology/Inflammation |
TLR7/8-IN-1,是一种结晶态TLR7/TLR8抑制剂,对于自身免疫性疾病研究具有重要价值[1]。 | |||
T15660 |
KHK-IN-1
KHK-IN-8,Ketohexokinase inhibitor 8 |
Others | Others |
KHK-IN-1 (KHK-IN-8) 是一种选择性的、细胞膜渗透性的己酮糖激酶 (KHK) 抑制剂 (IC50=12 nM; F=34%)。KHK-IN-1 抑制 HepG2 细胞裂解液中 F1P 生成,IC50为400 nM。KHK-IN-1 可用于研究糖尿病和肥胖症。 | |||
T12345 |
CBP/p300-IN-3
P300/CBP-IN-3 |
Histone Acetyltransferase | Chromatin/Epigenetic |
CBP/p300-IN-3 (P300/CBP-IN-3) 是一种组蛋白乙酰转移酶抑制剂。 | |||
T28865 |
STAT3-IN-B9
STAT3 IN B9,B9 |
STAT | JAK/STAT signaling; Stem Cells |
STAT3-IN-B9 (B9) 是异常 STAT3 激活的抑制剂,可抑制 MDA-MB-468、MDA-MB-231 和 DU145 等肿瘤细胞的增殖。 | |||
T39752 |
CDK12-IN-2
CDK12 inhibitor 2,CDK12-IN-2 |
CDK | Cell Cycle/Checkpoint |
CDK12-IN-2 (CDK12 inhibitor 2) 是一种有效的选择性 CDK12 抑制剂,对 CDK12、CDK2、CDK7 和 CDK9 的 IC50 为 52 nM、>100 μM、>10 μM 和 16 μM。 CDK12-IN-2可用于研究CDK12的功能。 | |||
T78823 |
Quorum Sensing-IN-3
QS-IN-1 |
Antibacterial | Microbiology/Virology |
Quorum Sensing-IN-3 (QS-IN-1)是一种对细菌群体感应有抑制作用的化合物,可抑制细菌之间的信息交流,抑制生物膜的形成。 | |||
T79607 |
h-NTPDase-IN-2
hNTPDase-IN-2 |
Phosphatase | Metabolism |
h-NTPDase-IN-2 是一种广谱 NTPDase 抑制剂,对多种 h-NTPDas 亚型都具有抑制作用。 | |||
T39669 |
TLR7/8/9-IN-1
TLR7/8/9-IN-1 |
TLR | Immunology/Inflammation |
TLR7/8/9-IN-1 是具有口服活性的Toll 样受体7/8/9小分子拮抗剂,IC50为43 nM。 | |||
T24133 |
HDAC8-IN-20a
HDAC8 IN 20a,HDAC8IN20a,HDAC8 inhibitor-20a,HDAC8 inhibitor 20a |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
HDAC8-IN-20a (HDAC8 inhibitor-20a) 是一种有效的、具有选择性的HDAC8抑制剂,IC50为27 nM。HDAC8-IN-20a 可阻断生长受体存活信号的激活。 | |||
T11580 |
Heme Oxygenase-1-IN-1
HO-1-IN-1 |
Reactive Oxygen Species | Immunology/Inflammation; Metabolism; NF-κB |
Heme Oxygenase-1-IN-1 (HO-1-IN-1) 是一种血红素加氧酶 1 (HO-1) 抑制剂,IC50=250 nM。 | |||
T29017 |
TrxR1-IN-B19
TrxR1INB19,Go Y015,TrxR1 IN B19,Go-Y015 |
Others | Others |
TrxR1-IN-B19 (TrxR1 IN B19) 是一种 TrxR1 抑制剂,通过靶向 TrxR1 和 ROS 介导的 ER 应激激活,通过小分子选择性杀死胃癌细胞。 | |||
T24131 |
HDAC3-IN-T247
HDAC3 inhibitor T247,HDAC3 inhibitor-T247,HDAC3 IN T247,T247 |
Histone Demethylase; Antiviral | Chromatin/Epigenetic; Immunology/Inflammation |
HDAC3-IN-T247 (HDAC3 inhibitor T247) 是一种具有选择性和有效性的组蛋白去乙酰化酶 3(HDAC3) 抑制剂,具有抗癌和抗病毒活性。HDAC3-IN-T247 以剂量依赖的方式诱导人结肠癌 HCT116 细胞中 NF-κB 乙酰化。HDAC3-IN-T247 抑制癌细胞增殖。 | |||
T24410 |
LIMK-IN-22j
LIMK IN 22j,LIMK inhibitor-22j,LIMK inhibitor 22j |
LIM Kinase | Cell Cycle/Checkpoint |
LIMK-IN-22j (LIMK inhibitor 22j) 是一种有效的选择性 LIMK 抑制剂。 | |||
T24793 |
SIRT6-IN-5
SIRT6 inhibitor5,SIRT6 IN 5,SIRT6 inhibitor-5,SIRT6 inhibitor 5 |
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
SIRT6-IN-5(SIRT6 inhibitor 5) 是一种具有有效性和选择性的 SIRT6 抑制剂 ,IC50 值为 34 μM。SIRT6-IN-5 具有免疫抑制和化疗增敏作用,可增加 H3K9 的乙酰化并增加培养细胞中的葡萄糖摄取,减少 T 细胞增殖。 | |||
T23709 |
alphaSYN-IN-NAB2
alphaSYN inhibitor NAB2,alphaSYNINNAB2,alphaSYN-IN-NAB2,NAB2,alphaSYN inhibitor-NAB2 |
||
alphaSYN-IN-NAB2 是一种神经元保护剂,是一种由 NAB2基因编码的蛋白质。NAB2 高效且具有选择性地保护多种细胞免受 α-syn 毒性。NAB2 对依赖于 E3 泛素连接酶 Rsp5/Nedd4 的内体转运具有促进作用。NAB2 确定 α-syn 生物学中的一个可活性分子节点,该节点可以纠正其潜在病理学的多个方面,包括功能失调的内体和内质网到高尔基体囊泡的运输。NAB2参与细胞分化、凋亡和应激反应等细胞过程,可用来研究癌症、神经发育和神经元活动。 | |||
T23867 |
Cdc7-IN-7c
Cdc7 inhibitor-7c,Cdc7 inhibitor 7c,Cdc7 IN 7c |
CDK | Cell Cycle/Checkpoint |
Cdc7-IN-7c (Cdc7 inhibitor-7c) 具有抗肿瘤活性,对肝癌,肺癌,肾癌,脑癌,宫颈癌有抑制作用。 | |||
T9017 |
HPK1-IN-2
Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2,HPK1-IN-2 |
Others; FLT; Src | Angiogenesis; Others; Tyrosine Kinase/Adaptors |
HPK1-IN-2 (Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2) 是一种有效且具有口服活性的造血祖细胞激酶-1 抑制剂(HPK1;IC50<0.05 µM)。它还抑制 Lck (0.05 µM<IC50<0.5 µM) 和 Flt3 (IC50<0.05 µM) 激酶活性,具有抗肿瘤活性。 | |||
T15782 |
Lp-PLA2-IN-1
Lp-PLA2 inhibitor 1,Lp-PLA2 -IN-1 |
Phospholipase | Metabolism |
Lp-PLA2-IN-1 (Lp-PLA2 inhibitor 1) 是脂蛋白相关磷脂酶 A2(Lp-PLA2) 抑制剂。它有潜力用于动脉粥样硬化、阿尔茨海默氏病的研究。 | |||
T63208L |
Aβ-IN-1 TFA
Aβ-IN-1 TFA(2766509-32-2 Free base) |
||
Aβ-IN-1 TFA 能够抑制和逆转不同类型的蛋白质聚集。 | |||
T3161L |
BACE-IN-1 acetate
BACE-IN-1 acetate (350228-37-4,Free base) |
BACE | Neuroscience |
BACE-IN-1 acetate (BACE-IN-1 acetate (350228-37-4,Free base)) 已被用作 BACE1 抑制剂测定中的 β 位淀粉样前体蛋白 (APP) 裂解酶-1 (BACE1) 抑制剂。 β-位点淀粉样前体蛋白 (APP) 切割酶-1 (BACE1)是一种天冬氨酸蛋白酶,属于蛋白酶家族,由六个腔内半胱氨酸残基组成。这些残基有助于形成三个分子间二硫键和 N-连接的糖基化位点。 | |||
T10792L |
CHK1-IN-4 hydrochloride
CHK1-IN-4 hydrochloride(2120398-41-4 Free base) |
Chk | Cell Cycle/Checkpoint |
CHK1-IN-4 hydrochloride 是有效的checkpoint kinase 1 (chk1) 抑制剂,对肿瘤细胞中 chk1 磷酸化具有有效的抑制作用。CHK1-IN-4 hydrochloride 显示出抗肿瘤活性。 | |||
T19206 |
β-Lactamase-IN-1
4-(1,3-dihydroxypropan-2-yl)-6-methoxypyrido[2,3-b]pyrazin-3-one,beta-lactamase-IN-1 |
Antibacterial | Microbiology/Virology |
β-Lactamase-IN-1 (4-(1,3-dihydroxypropan-2-yl)-6-methoxypyrido[2,3-b]pyrazin-3-one) 是一种 β-Lactamase 抑制剂,针对淋病奈瑟菌的感染。 | |||
T28652 |
S6K1-IN-DG2
S6K1 Inhibitor DG2,S6K1-Inhibitor-DG2,S6K1 IN DG2,S6K1INDG2,S6K1InhibitorDG2 |
mTOR | PI3K/Akt/mTOR signaling |
S6K1-IN-DG2(S6K1InhibitorDG2) 是一种有效的 p70S6K 抑制剂 ,IC50 值小于 100 nM。 | |||
TP2160L1 |
YAP-TEAD-IN-1 acetate
YAP-TEAD-IN-1 acetate (1659305-78-8 Free base) |
YAP | Stem Cells |
YAP-TEAD-IN-1 acetate 是一种有效的、竞争性的 YAP-TEAD 相互作用抑制剂,IC50 为 25 nM。 | |||
T23897 |
CLK1/2-IN-3
CLK1/2 inhibitor 3,CLK1/2-inhibitor-3,CLK1/2 IN 3,CLK1/2IN3 |
CDK | Cell Cycle/Checkpoint |
CLK1/2-IN-3(Cpd-3) 是一种具有高效性和选择性的 CLK1 和 CLK2 抑制剂,抗增殖活性,抑制 CLK1、CLK2、SRPK1、SRPK2、SRPK3 的 的活性。CLK1/2-IN-3 可诱导核斑点扩大,可诱导S6K pre-mRNA选择性剪接和随后抑制多种癌细胞类型细胞生长。 | |||
T15572 |
IN-1130
|
ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
IN-1130 是一种选择性的 ALK5 抑制剂,对 ALK5 介导的 Smad3 磷酸化、酪蛋白和 p38α 丝裂原活化蛋白激酶的 ALK5 磷酸化,IC50 值为 5.3 nM、36 nM 和 4.3 μM。 | |||
T63399L |
mTOR/HDAC-IN-1 HCl
mTOR/HDAC-IN-1 HCl(2815286-02-1 Free base) |
HDAC; mTOR | Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
mTOR/HDAC-IN-1 HCl 是一种有效的 mTOR 和 HDAC 双重抑制剂,具有潜在的抗炎、抗增殖、自噬和诱导凋亡作用,可用于研究癌症。mTOR/HDAC-IN-1 HCl 是一种有效的 mTOR 和 HDAC 双重抑制剂,具有潜在的抗炎、抗增殖、自噬和凋亡诱导作用,可用于研究癌症。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5070 |
LC3-mHTT-IN-AN2
5,7-二羟基-4-苯基香豆素,5,7-Dihydroxy-4-phenylcoumarin |
Antibacterial; Autophagy; ATTECs | Autophagy; Microbiology/Virology; PROTAC |
LC3-mHTT-IN-AN2 (5,7-Dihydroxy-4-phenylcoumarin) 是一种 mHTT-LC3 接头化合物,可与突变亨廷顿蛋白(mHTT) 和 LC3B 相互作用。 它将 mHTT 靶向自噬体以等位基因选择性方式降低培养的亨廷顿病小鼠神经元中的 mHTT 水平。它存在于西番莲植物中,具有抗菌活性。 | |||
T19289 |
DL-Glyceric Acid
Glyceric Acid (20% in Water,ca.2 mol/L) |
Others | Others |
DL-glyceric acid is a compound that is excessively secreted in the urine of patients with D-glyceric aciduria. | |||
T73070 |
STAT3-IN-14
|
||
STAT3-IN-14是一种STAT3抑制剂,具有STAT3磷酸化抑制活性,可直接与 STAT3的铰链区结合。 | |||
T75511 | BChE-IN-10 | ||
BChE-IN-10 (compound 6),一种从白芨 (Bletilla striata) 分离提取的丁酰胆碱酯酶 (BChE) 混合型抑制剂,具有 6.4 μM 的IC50,适用于阿尔兹海默症 (AD) 研究。 | |||
T81684 |
Neuroinflammatory-IN-1
|
||
Neuroinflammatory-IN-1 (Compound 5),作为一种抗神经炎剂,对NO生成表现出显著的抑制效果,其IC50为65.4 μM。 | |||
T73073 |
PTP1B-IN-21
|
||
PTP1B-IN-21 是蛋白酪氨酸磷酸酶 1B (PTP1B) 的选择性抑制剂 (IC50=1.56 μM),抑制力超出高度同源 T 细胞蛋白酪氨酸磷酸酶 (TCPTP;IC50>100 μM),PTP1B 是抑制 2 型糖尿病的重要靶点。 | |||
T73202 |
BChE-IN-11
|
||
BChE-IN-11 是一种有效的、选择性的、非竞争性BChE(丁基胆碱酯酶)抑制剂,其IC50为 2.1 μM。BChE-IN-11 可用于阿尔茨海默病 (AD) 的研究。 | |||
T75545 | PCSK9-IN-9 | ||
PCSK9-IN-9 是一种天然来源的异香豆素。PCSK9-IN-9 可抑制原蛋白转化酶枯草菌素 kexin 型 9 (PCSK9)、IDOL 和 SREBP2的 mRNA 表达水平。PCSK9-IN-9 抑制 PCSK9的 IC50为 11.9 μM。 | |||
T75513 | BChE-IN-12 | ||
BChE-IN-12 (compound 12) 为一种高效BChE非竞争性抑制剂,其IC50值为2.3 μM。该化合物可从白芨(Bletilla striata)中分离提取,适用于阿尔兹海默症(AD)的研究。 | |||
T73072 |
PTP1B-IN-20
|
||
PTP1B-IN-20 是蛋白酪氨酸磷酸酶 1B (PTP1B) 的选择性抑制剂 (IC50=1.05 μM),抑制力超出高度同源 T 细胞蛋白酪氨酸磷酸酶 (TCPTP;IC50=78.0 μM),PTP1B 是抑制 2 型糖尿病的重要靶点。 | |||
T81629 |
OAT1/3-IN-2
|
||
OAT1/3-IN-2(化合物8)是一种针对OAT1和OAT3的双重抑制剂。该化合物能够以10 μM的浓度逆转Cys-Hg对HEK-OAT1细胞的毒害作用,并可能对肾脏具有保护效应。OAT1/3-IN-2适用于研究汞导致的肾脏损伤。 | |||
T80713 |
α-Glucosidase-IN-37
|
||
α-Glucosidase-IN-37(Compound 11)展示出中等水平的抑制作用,能够抑制LPS诱导的NO产生,并在巨噬细胞中表现出23.7 μM的IC50值。该化合物对α-Glucosidase的抑制活性相对较弱。 | |||
T75612 | α-Glucosidase-IN-24 | ||
α-Glucosidase-IN-24 (Compound 13) 是一种α-Glucosidase 抑制剂,IC50为 451 μM,可以从Swertia kouitchensis 中分离得到。 | |||
T75544 | AChE/BChE-IN-11 | ||
AChE/BChE-IN-11 (compound 1) 是一种有效的 AChE 和 BChE 双重抑制剂,AChE 和BChE 的IC50值为分别为 70 和 71 μM。AChE/BChE-IN-11 是一种天然产物,可以从朝鲜蓟叶中分离得到。AChE/BChE-IN-11 可用于阿尔茨海默病 (AD) 研究。 | |||
T75504 | Xanthine oxidase-IN-8 | ||
Xanthine oxidase-IN-8 (Icarisids J) (Compound 7) 是一种 XOD 抑制剂,IC50值为 29.71 μM。 | |||
T75505 | Xanthine oxidase-IN-9 | ||
Xanthine oxidase-IN-9 (Icarisids E) (Compound 2),一种黄嘌呤氧化酶 (XOD) 高效抑制剂,具有31.81 μM 的 IC50 值。 | |||
T81630 |
OAT1/3-IN-1
|
||
OAT1/3-IN-1(化合物7)是针对OAT1和OAT3的双重抑制剂。该化合物能逆转Cys-Hg(10 μM)对HEK-OAT1细胞引起的毒害,表明其对肾脏有潜在的保护效应。OAT1/3-IN-1适合用于探究汞引起的肾脏损伤机制研究。 | |||
T72581 |
SARS-CoV MPro-IN-2
|
||
SARS-CoVMPro-IN-2 是一种有效的SARS-CoV-2 Mpro 抑制剂,IC50sub>值为 72.07 nM。病毒的主要蛋白酶 Mpro 作为加工病毒多蛋白的主要酶,有助于 SARS-CoV-2 在宿主细胞中的复制和转录,并已被定性为药物发现的有吸引力的靶点。SARS-CoVMPro-IN-2 具有研究 COVID-19 的潜力。 | |||
TN3270 |
(R)-3β-Hydroxy steroid sulfotransferase-IN-11
|
Others | Others |
(R)-3β-Hydroxy steroid sulfotransferase-IN-11 在生命科学相关研究中具有广泛的应用。 | |||
TJS1779 |
Protosappanin A
原苏木素A,PTA |
NADPH-oxidase; IL Receptor; IκB/IKK; TNF; NF-κB; TLR; ROS; COX; HIV Protease; JAK; NO Synthase; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Immunology/Inflammation; JAK/STAT signaling; Microbiology/Virology; Neuroscience; NF-κB; Proteases/Proteasome; Stem Cells |
Protosappanin A (PTA) 是从苏木中分离得到的免疫抑制成分和主要联苯化合物,通过下调 JAK2和 STAT3的磷酸化,抑制 JAK2/STAT3依赖的炎症通路。 | |||
T1879 |
3-Methyladenine
3-MA,3-甲基腺嘌呤,NSC 66389 |
Mitophagy; PI3K; Endogenous Metabolite; Autophagy | Autophagy; Metabolism; PI3K/Akt/mTOR signaling |
3-Methyladenine (3-MA) 是一种 PI3K 抑制剂,选择性抑制 IB 类 PI3Kγ (IC50=60 μM) 和 III 类 VPS34 (IC50=25 μM)。3-Methyladenine 具有自噬抑制活性。 | |||
T19146 |
5,6-Dihydrouridine
|
Endogenous Metabolite | Metabolism |
5,6-Dihydrouridine 是一种修饰碱基,存在于真核生物、细菌和某些古细菌tRNA D 环的保守位置。 | |||
T4898 |
Potassium 1-carboxyvinyl hydrogenphosphate
PEP-K,磷酸烯醇丙酮酸单钾盐,Phospho(enol)pyruvic acid monopotassium |
Others; Endogenous Metabolite | Metabolism; Others |
Potassium 1-carboxyvinyl hydrogenphosphate (PEP-K) 是内源性代谢产物的一种。 | |||
T15157 |
Dodecanoylcarnitine
Lauroylcarnitine |
Endogenous Metabolite | Metabolism |
Dodecanoylcarnitine((-)-Lauroylcarnitine) 和脂肪酸氧化紊乱有关,使用 Dodecanoylcarnitine 可使鲑鱼降钙素的通透性增加。 | |||
T20225 |
Dicentrine, (-)-
L-Dicentrine,荷包牡丹碱,NSC 251699,NSC251699,NSC-251699 |
Others | Others |
Dicentrine, (-)- (NSC-251699) 是一种在几种植物物种中发现的非卟啉生物碱,在小鼠内脏痛的急性模型中显示出显著的镇痛活性。 | |||
T4722 |
O-Acetyl-L-serine hydrochloride
|
Others; Endogenous Metabolite | Metabolism; Others |
O-Acetyl-L-serine hydrochloride 是内源性代谢产物的一种。 | |||
TN1698 |
Glucotropaeolin potassium
金莲葡糖硫苷钾盐,Glucotropaeolin,Benzylglucosinolate potassium,Glucotropaeolin Potassium Salt |
Others | Others |
Glucotropaeolin potassium (Benzylglucosinolate potassium) 存在于十字花科蔬菜中,并且 可适度减少动物的自发性DNA 损伤。 | |||
T4809 |
Pyrimidine
嘧啶,Metadiazine |
Others; Endogenous Metabolite | Metabolism; Others |
Pyrimidine (Metadiazine) 是内源性代谢产物的一种。 | |||
T5282 |
5-Methyluridine
Ribothymidine,5-甲基尿甙,Thymine riboside |
Others; Endogenous Metabolite | Metabolism; Others |
5-Methyluridine (Thymine riboside) 是发现于人体液中的内源性甲基化核苷。 | |||
T5076 |
L-Allothreonine
L-别苏氨酸,L-allo-Threonine |
Others; Endogenous Metabolite | Metabolism; Others |
L-Allothreonine (L-allo-Threonine) 是内源性代谢产物的一种。 | |||
T4969 |
Guanosine 5'-triphosphate trisodium salt
鸟苷-5'-三磷酸三钠盐,GTP Trisodium salt,5'-GTP trisodium salt |
Endogenous Metabolite | Metabolism |
Guanosine 5'-triphosphate trisodium salt (5'-GTP trisodium salt) 为G蛋白(G proteins)信号转导过程中的活化剂。 | |||
TJS0387 |
Desoxyrhaponticin
去氧土大黄苷,Deoxyrhapontin,脱氧土大黄苷,Deoxyrhaponticin |
Apoptosis; Fatty Acid Synthase | Apoptosis; Metabolism |
Desoxyrhaponticin (Deoxyrhaponticin) 是来自西藏营养食品唐古特大黄中的一种二苯乙烯苷。它是脂肪酸合成酶抑制剂,抑制细胞内 FAS 活性,下调人乳腺癌 MCF-7细胞中 FAS 的表达。它是控制糖尿病餐后高血糖的潜在药物。 | |||
T4713 |
Phosphorylcholine chloride calcium salt tetrahydrate
Phosphocholine chloride calcium salt tet,胆碱磷酸氯化钙四水,CalciuM Phosphorylcholine Tetrahydrate |
Others; Endogenous Metabolite | Metabolism; Others |
Phosphorylcholine chloride calcium salt tetrahydrate (Phosphocholine chloride calcium salt tet) 是内源性代谢产物的一种。 | |||
T0710 |
L-Cycloserine
Levcycloserine,Levcicloserina,(-)-Cycloserine,(S)-Cycloserine,Levcycloserinum,环丝氨酸,(S)-4-Amino-3-isoxazolidone |
HIV Protease; GABA Receptor | Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
L-Cycloserine ((-)-Cycloserine) 不可逆地抑制大肠杆菌以及各种动物大脑中的 GABA 吡哆醛 5'-磷酸依赖性转氨酶,导致体内抑制性神经递质 γ-氨基丁酸水平升高。 | |||
T5875 |
4-Methoxycinnamic acid
|
Endogenous Metabolite | Metabolism |
4-Methoxycinnamic acid 是天然苯丙烷类化合物。 | |||
T13509 |
4-Vinylphenol
|
Apoptosis; Endogenous Metabolite | Apoptosis; Metabolism |
4-Vinylphenol 是酒中乳酸菌对香豆酸和阿魏酸的代谢产物,在白花蛇舌草中发现。 4-Vinylphenol 在体内诱导细胞凋亡。 | |||
T3O2784 |
Vitamin B6
维生素B6 |
Others | Others |
Vitamin B6 是人体某些辅酶的成分,参与多种代谢反应,特别是与氨基酸代谢有关。维生素B6在防治妊娠和放射病呕吐中的临床应用。 | |||
TQ0273 |
Neopterin
D-(+)-Neopterin,2-Amino-6-((1S,2R)-1,2,3-trihydroxypropyl)pteridin-4(3H)-one,新蝶呤 |
Endogenous Metabolite | Metabolism |
Neopterin (D-(+)-Neopterin) 是三磷酸腺苷的一种分解产物,是细胞免疫系统激活的标志物。 | |||
T4104 |
Ophiopojaponin C
麦冬皂苷C,Ophiopogonin C |
Others | Others |
Ophiopogonin C' pharmacological activities may be related to the substances in nucleus mainly. | |||
T5647 |
6-Methylcoumarin
Toncarine,6-甲基香豆素 |
Others | Others |
6-Methylcoumarin (Toncarine) 是一种合成香料,广泛用于化妆品中。 | |||
T3S0693 |
Blinin
|
Others | Others |
Blinin 是一种二萜,分离自植物 Conyza blinii 中。 | |||
T5812 |
Zinc Phytate
|
Others | Others |
Zinc Phytate 存在于食物中,对人类吸收营养有重要意义。 | |||
T4814 |
(R)-5-Oxopyrrolidine-2-carboxylic acid
D-Pyroglutamic acid,(R)-(+)-2-Pyrrolidone-5-carboxylic acid,D-焦谷氨酸 |
Others; Endogenous Metabolite | Metabolism; Others |
(R)-5-Oxopyrrolidine-2-carboxylic acid (D-Pyroglutamic acid) 是内源性代谢产物的一种。 | |||
T3912 |
Saikosaponin B1
柴胡皂苷B1,柴胡皂苷 B1 |
Others | Others |
Saikosaponin B1 是柴胡的生物活性成分,具有抗癌作用。它能够靶向SMO 抑制 Hedgehog 通路,显著抑制髓母细胞瘤模型中的肿瘤生长。 | |||
T5309 |
Dimethylamine hydrochloride
N,N-Dimethylamine,二甲胺盐酸盐 |
Others | Others |
Dimethylamine hydrochloride (N,N-Dimethylamine) 大量存在于人类尿液中。 | |||
TN5086 |
Syringetin
|
Others | Others |
Syringetin 是一种存在于葡萄和葡萄酒中的类黄酮衍生物,可促进 B16F10 细胞的黑色素生成,抑制人肺腺癌中成骨细胞介导的破骨细胞生成。 | |||
T0925 |
Allantoin
Glyoxyldiureide,尿囊素,5-Ureidohydantoin |
Endogenous Metabolite; Imidazoline Receptor | Metabolism; Neuroscience |
Allantoin (Glyoxyldiureide) 是一种存在于尿液和植物中的尿素乙内酰脲,用于皮肤病制剂。 | |||
T24711 |
Ricinine
1,2-Dihydro-4-methoxy-1-methyl-2-oxonicotinonitrile,蓖麻碱,Ricinin,Ritsinin |
Others | Others |
Ricinine (1,2-Dihydro-4-methoxy-1-methyl-2-oxonicotinonitrile) 是蓖麻植物中的一种主要生物碱,在 CCl4 诱导的肝损伤中具有保肝作用。 | |||
T5S0890 |
Oleandrin
Neriostene,Folinerin,Foliandrin,欧夹竹桃苷 |
Apoptosis; ATPase; Potassium Channel; Sodium Channel | Apoptosis; Membrane transporter/Ion channel |
Oleandrin (Folinerin) 是夹竹桃属中的一种类固醇,可抑制Na+/K+-ATPase 活性,IC50为 620 nM。 | |||
T4852 |
Trimyristin
Trimyristoylglycerol,Tritetradecanoin,三肉豆蔻酸甘油酯,Glyceryl trimyristate,甘油三肉豆蔻酸酯,1,2,3-Tritetradecanoylglycerol |
Phosphatase; Endogenous Metabolite; AChE | Metabolism; Neuroscience |
Trimyristin (Tritetradecanoin) 是一种 Myristica fragransHoutt 的有效成分,能够显著抑制乙酰胆碱酯酶 (AChE),酸性和碱性磷酸酶 (ACP/ALP) 特性。它对 AChE,ACP 和 ALP 的 IC50分别为 0.11、0.16 和 0.18 mM。 | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01442 |
DMBT1 Protein, Human, Recombinant (His)
GP340,deleted in malignant brain tumors 1,... |
Human | HEK293 Cells |
Deleted in malignant brain tumors 1 protein, also known as glycoprotein 34, surfactant pulmonary-associated D-binding protein, DMBT1 and GP34, is a secreted protein which belongs to theDMBT1 family. DMBT1 contains 2CUB domains, 14SRCR domains and 1ZP domain. It is highly expressed in alveolar and macrophage tissues. In some macrophages, expression is detected on the membrane, and in other macrophages, it is strongly expressed in the phagosome/phagolysosome compartments. Defects in DMBT1 are invo... | |||
TMPY-02033 |
CD44 Protein, Human, Recombinant (His)
CD44 molecule (Indian blood group),IN,MC56... |
Human | HEK293 Cells |
CD44 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23.4 kDa and the accession number is P16070-1. | |||
TMPY-01775 |
AIM2 Protein, Human, Recombinant (GST)
absent in melanoma 2,PYHIN4 |
Human | Baculovirus Insect Cells |
AIM2, Absent In Melanoma 2 is a member of the interferon-inducible HIN-200 protein family that contains an amino-terminal pyrin domain and a carboxy-terminal oligonucleotide/oligosaccharide-binding domain, senses cytoplasmic DNA by means of its oligonucleotide/oligosaccharide-binding domain and interacts with ASC (apoptosis-associated speck-like protein containing a CARD) through its pyrin domain to activate caspase-1. In response to foreign cytoplasmic DNA, AIM2 forms an inflammasome, resulting... | |||
TMPY-03430 |
RheB Protein, Human, Recombinant (His)
Ras homolog enriched in brain,RHEB2 |
Human | Baculovirus Insect Cells |
RHEB is a recently discovered member of the Ras superfamily that may be involved in neural plasticity. This function is novel and not typically associated with the Ras proteins. RHEB gene is a member of the small GTPase superfamily and encodes a lipid-anchored, cell membrane protein with five repeats of the RAS-related GTP-binding region. RHEB is vital in regulation of growth and cell cycle progression due to its role in the insulin / TOR / S6K signaling pathway. The protein has GTPase activity ... | |||
TMPJ-01125 |
PEA15 Protein, Human, Recombinant
15 kDa Phosphoprotein Enriched in Astrocyt... |
Human | E. coli |
Astrocyticphosphoprotein PEA-15 (PEA15) is a death effector domain (DED)-containing protein. PEA15 is mainly expressed in the central nervous system, principally in astrocytes. Increased PEA15 levels affect tumorigenesis and cancer progression. PEA15 is overexpressed in breast cancers and gliomas as well as in type 2 diabetes. PEA15 blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. PEA15 also inhibits RPS6KA3 activities by holding it in the cytoplasm... | |||
TMPY-00580 |
DCUN1D2 Protein, Human, Recombinant (His)
DCN1, defective in cullin neddylation 1, d... |
Human | E. coli |
DCUN1D2 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 32.4 kDa and the accession number is Q6PH85-1. | |||
TMPJ-01126 |
RheB Protein, Human, Recombinant (GST)
RHEB,Ras Homolog Enriched in Brain,GTP-B |
Human | E. coli |
GTP-Binding Protein Rheb (RHEB) is a member of the small GTPase superfamily and encodes a lipid-anchored, cell membrane protein with five repeats of the RAS-related GTP-binding region. Highest levels of RHEB can be found in the skeletal and cardiac muscle, and it is vital in the regulation of growth and cell cycle progression due to its role in the Insulin/TOR/S6K signaling pathway. RHEB stimulates the phosphorylation of S6K1 and EIF4EBP1 through activation of mTORC1 signaling, and it activates... | |||
TMPJ-01387 |
PACSIN2 Protein, Human, Recombinant (His)
Protein Kinase C and Casein K... |
Human | HEK293 Cells |
Protein Kinase C and Casein Kinase Substrate in Neurons Protein 2 (PACSIN2) is a member of the PACSIN family. PACSIN2 is localized to the plasma membrane via its coiled-coil domain. PACSIN2 is widely expressed and contains one FCH domain and one SH3 domain. PACSIN2 forms homo- and hetero-aggregates with other PACSINs. PACSIN2 may play a role in vesicle formation and transport. In addition, PACSIN2 is involved in linking the actin cytoskeleton with vesicle formation by regulating tubulin polymeri... | |||
TMPJ-00272 |
RELT/TNFRSF19L Protein, Human, Recombinant (hFc)
RELT,TNFRSF19L,Receptor expressed in lymphoid tissu... |
Human | HEK293 Cells |
Tumor necrosis factor receptor superfamily member 19L (TNFRSF19L), also known as Receptor expressed in lymphoid tissues and RELT, is a member of the TNF-receptor superfamily. TNFRSF19L is a single-pass type membrane protein and contains one TNFR-Cys repeat. TNFRSF19L is highly expressed in spleen, lymph node, thymus, peripheral blood leukocytes, bone marrow and fetal liver. It has been shown TNFRSF19L activates the NF-kappaB pathway and selectively binds TNF receptor-associated factor 1 (TRAF1).... | |||
TMPY-01710 |
IkB alpha/NFKBIA Protein, Human, Recombinant (His)
IkB α,IKBA,nuclear factor of kappa light polypeptide gene en... |
Human | E. coli |
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IkB alpha, NFKBIA, or IKBA), is a member of the NF-kappa-B inhibitor family that function to inhibit the NF-kB transcription factor. NFKBIA inhibits NF-kB by masking the nuclear localization signals (NLS) of NF-kB proteins and keeping them sequestered in an inactive state in the cytoplasm. Also, NFKBIA blocks the ability of NF-κB transcription factors to bind to DNA, which is required for NF-kB's proper function... | |||
TMPJ-01307 |
PACSIN1 Protein, Human, Recombinant (His)
Protein Kinase C and Casein K... |
Human | HEK293 Cells |
Protein Kinase C and Casein Kinase Substrate in Neurons Protein 1 (PACSIN1) belongs to the PACSIN family. PACSIN1 contains one FCH domain and one SH3 domain. PACSIN1 is highly expressed in the brain and at lower leves in the heart, pancreas, and liver. PACSIN1 may play a role in vesicle formation and transport. PACSIN1 has been shown to interact with DNM1, PACSIN3, Huntingtin, and PACSIN2. In addition, PACSIN1 is phosphorylated by casein kinase 2 (CK2) and protein kinase C (PKC). | |||
TMPH-03747 |
CCDC112 Protein, Human, Recombinant (His & Myc)
Mutated in bladder cancer protein 1,Coiled... |
Human | E. coli |
CCDC112 Protein, Human, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 61.0 kDa and the accession number is Q8NEF3. | |||
TMPH-01091 |
CHD1L Protein, Human, Recombinant (His & SUMO)
Amplified in liver cancer protein 1,CHD1L,... |
Human | E. coli |
DNA helicase which plays a role in chromatin-remodeling following DNA damage. Targeted to sites of DNA damage through interaction with poly(ADP-ribose) and functions to regulate chromatin during DNA repair. Able to catalyze nucleosome sliding in an ATP-dependent manner. Helicase activity is strongly stimulated upon poly(ADP-ribose)-binding. CHD1L Protein, Human, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 37.3 kDa an... | |||
TMPY-03869 |
DCUN1D1 Protein, Human, Recombinant (His)
DCNL1,SCCRO,Tes3,RP42,SCRO,DCUN1L1,DCN1, defective in |
Human | E. coli |
DCUN1D1, also known as SCCRO, is part of an E3 ubiquitin ligase complex for neddylation. DCUN1D1 functions to recruit charged E2 and is involved in the release of inhibitory effects of CAND1 on cullin-RING ligase E3 complex assembly and activity. DCUN1D1 binds to the components of the neddylation pathway (Cullin-ROC1, Ubc12, and CAND1) and augments but is not required for cullin neddylation in reactions using purified recombinant proteins. DCUN1D1 also recruits Ubc12 approximately NEDD8 to the C... | |||
TMPJ-00887 |
NFKB1 Protein, Human, Recombinant (His)
Nuclear factor of κ light polypeptide gene enhancer in |
Human | E. coli |
The 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory... | |||
TMPH-00252 |
Bovine coronavirus (strain Mebus) Protein I (His)
IORF,Protein in nucleocapsid ORF,N,I,Acces... |
BCoV | E. coli |
Structural protein that is not essential for the viral replication either in tissue culture or in its natural host. Bovine coronavirus (strain Mebus) Protein I (His) is expressed in E. coli expression system with C-6xHis tag. The predicted molecular weight is 25.5 kDa and the accession number is P10525. | |||
TMPH-00255 |
Bovine coronavirus (strain LSU-94LSS-051) Protein I (His)
N internal ORF protein,Accessory prote... |
BCoV | E. coli |
Structural protein that is not essential for the viral replication either in tissue culture or in its natural host. Bovine coronavirus (strain LSU-94LSS-051) Protein I (His) is expressed in E. coli expression system with C-6xHis tag. The predicted molecular weight is 24.4 kDa and the accession number is Q9QAR0. | |||
TMPH-00253 |
Bovine coronavirus (strain 98TXSF-110-LUN) Protein I (His)
IORF,N,Protein in nucleocapsid ORF,N i... |
BCoV | E. coli |
Structural protein that is not essential for the viral replication either in tissue culture or in its natural host. Bovine coronavirus (strain 98TXSF-110-LUN) Protein I (His) is expressed in E. coli expression system with C-6xHis tag. The predicted molecular weight is 24.4 kDa and the accession number is Q8V431. | |||
TMPH-00256 |
Bovine coronavirus (strain LY-138) Protein I (His)
I,N internal ORF protein,N,Accessory prote... |
BCoV | E. coli |
Structural protein that is not essential for the viral replication either in tissue culture or in its natural host. Bovine coronavirus (strain LY-138) Protein I (His) is expressed in E. coli expression system with C-6xHis tag. The predicted molecular weight is 25.4 kDa and the accession number is Q9QAR7. | |||
TMPH-00254 |
Bovine coronavirus (strain 98TXSF-110-ENT) Protein I (His)
Protein I,N internal ORF protein,... |
BCoV | E. coli |
Structural protein that is not essential for the viral replication either in tissue culture or in its natural host. Bovine coronavirus (strain 98TXSF-110-ENT) Protein I (His) is expressed in E. coli expression system with C-6xHis tag. The predicted molecular weight is 24.0 kDa and the accession number is Q91A21. | |||
TMPJ-00467 |
Mindin Protein, Human, Recombinant (His)
Spondin-2,Differentially expressed in canc... |
Human | HEK293 Cells |
Spondin-2, also referred to as mindin, belongs to the F-spondin family of secreted extracellular matrix proteins. Spondins are characterised by the presence of F-spondin domains 1 and 2 (FS1 and FS2) at the N-terminus and a thrombospondin-type 1 repeat (TSR1) domain at the C-terminus. Spondin-2 functions as a pattern-recognition molecule for bacterial and viral pathogens and as an integrin ligand for inflammatory cell recruitment and T cell priming. In addition to its roles in promoting neuron o... | |||
TMPK-00518 |
CD44 Protein, Cynomolgus, Recombinant (His)
CDw44,IN,MIC4,CD44,ECMR-III,CSPG8,HCELL,HUTCH-I,MC5... |
Cynomolgus | HEK293 Cells |
CD44 is a hyaluronan binding cell surface signal transducing receptor that influences motility, cell survival and proliferation as well as the formation of tumor microenvironment. CD44 contains two variable regions encoded by variable exons. Alternative splicing, which is often deregulated in cancer, can produce various isoforms of CD44 with properties that may have different tissue specific effects and therefore even diverse effects on cancer progression | |||
TMPJ-00320 |
AMIGO2 Protein, Human, Recombinant (hFc)
DEGA,AMIGO-2,AMIGO2,ALI1,Alivin-1,Amphoterin |
Human | HEK293 Cells |
Amphoterin-Induced Protein 2 (AMIGO2) is a single-pass type I membrane protein which belongs to the AMIGO family of immunoglobulin superfamily. Mature AMIGO2 contains an Ig-like C2-type (immunoglobulin-like) domain, 6 LRR (leucine-rich) repeats, a LRRCT domain, as well as a LRRNT domain. AMIGO2 is mainly expressed in in breast, ovary, cervix, and uterus, although lower in lung, colon, and rectum. AMIGO2 required for depolarization-dependent survival of cultured cerebellar granule neurons. AMIGO2... | |||
TMPY-06551 |
CD44 Protein, Human, Recombinant
MDU3,LHR,MC56,CDW44,CSPG8,IN,MDU2,HCELL,Pgp1,CD44 m... |
Human | HEK293 Cells |
CD44 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 22.07 kDa and the accession number is P16070-1. | |||
TMPJ-00705 |
BCAS2 Protein, Human, Recombinant (His, T7)
BCAS2,DNA Amplified in Mammary Carcinoma 1... |
Human | E. coli |
Breast Carcinoma-Amplified Sequence 2 (BCAS2) is a member of the SPF27 family. BCAS2 is a nuclear protein and widely expressed in many rtissues. BCAS2 is identified as being overexpressed in various breast cancer cell lines. BCAS2 is a component of the spliceosome, taking part in the removal of introns from mRNA precursors. BCAS2 interacts with estrogen receptor alpha and beta, thyroid hormone receptor beta, peroxisome proliferator-activated receptor gamma. BCAS2 functions as an ER co-activator ... | |||
TMPY-03530 |
CD44 Protein, Human, Recombinant (hFc)
LHR,HCELL,CDW44,MDU3,MC56,MIC4,MDU2,HUTCH-I,IN,Pgp1... |
Human | HEK293 Cells |
CD44 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.1 kDa and the accession number is P16070-1. | |||
TMPH-01100 |
CLINT1 Protein, Human, Recombinant (His)
KIAA0171,Epsin-related protein,ENTH,CL... |
Human | E. coli |
Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). May have a role in transport via clathrin-coated vesicles from the trans-Golgi network to endosomes. Stimulates clathrin assembly. CLINT1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 72.3 kDa and the accession number is Q14677. | |||
TMPJ-01108 |
SMAD4 Protein, Human, Recombinant (His)
DPC4,SMAD 4,Deletion Target in Pancreatic Carci... |
Human | E. coli |
SMAD Family Member 4 (SMAD4) is a cytoplasmic protein that belongs to the Dwarfin/SMAD family. SMAD4 contains one MH1 (MAD homology 1) domain and one MH2 (MAD homology 2) domain. It is the component of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the nucleus and is required for the TGF-mediated signaling. SMAD4 promotes binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an activation function required for SMAD1 or SMAD2 to stimulate transcription. SMAD4 may act as a tumo... | |||
TMPJ-01156 |
PHLDA2 Protein, Human, Recombinant (His)
Beckwith-Wiedemann Syndrome Chromosomal Region 1 Candidate G... |
Human | E. coli |
Pleckstrin Homology-Like Domain Family A Member 2 (PHLDA2) is a peripheral membrane protein that belongs to the PHLDA2 family. PHLDA2 is expressed in the placenta and adult prostate gland. In the placenta, it is present in all cells of the villous cytotrophoblast. PHLDA2 plays a role in regulating placenta growth. PHLDA2 may act via its PH domain that competes with other PH domain-containing proteins, thereby preventing their binding to membrane lipids. | |||
TMPJ-00281 |
CADM1 Protein, Mouse, Recombinant (hFc)
IgSF4,NECL-2,Nectin-like protein 2,Immunog... |
Mouse | HEK293 Cells |
Cell adhesion molecule 1(CADM1) is a single-pass type I membrane protein and belongs to the nectin family. It contains 2 Ig-like C2-type (immunoglobulin-like) domains and 1 Ig-like V-type (immunoglobulin-like) domain. CADM1 acts as a tumor suppressor in non-small-cell lung cancer (NSCLC) cells. Interaction with CRTAM promotes natural killer (NK) cell cytotoxicity and interferon-gamma (IFN-gamma) secretion by CD8+ cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM3 in... | |||
TMPY-04531 |
p38 delta/MAPK13 Protein, Human, Recombinant (GST), Activated in vitro
P38 δ/MAPK13,MAPK13,PRKM13,MAPK-13,p38δ,p38delta,mitogen-act... |
Human | Baculovirus Insect Cells |
p38 delta/MAPK13 Protein, Human, Recombinant (GST), Activated in vitro is expressed in Baculovirus insect cells with GST tag. The predicted molecular weight is 68.4 kDa and the accession number is O15264. | |||
TMPJ-00234 |
AMBP Protein, Human, Recombinant (His)
α-1-Microglobulin,Uronic-Acid-Rich Protein... |
Human | HEK293 Cells |
Protein AMBP belongs to the calycin superfamily and Lipocalin family. AMBP can be cleaved into three chains: α-1-microglobulin, inter-α-trypsin inhibitor light chain and trypstatin. AMBP is expressed by the liver and secreted in plasma. α-1-microglobulin occurs in many physiological fluids including the plasma, urine, and cerebrospinal fluid. Inter-α-trypsin inhibitor is present in the plasma and urine. α-1-microglobulin occurs as a monomer and also in complexes with IgA and albumin, Inter-α-try... | |||
TMPY-01009 |
TGFBI Protein, Human, Recombinant (His)
CDG2,CSD,EBMD,CSD1,CDGG1,CSD3,transforming growth f... |
Human | HEK293 Cells |
TGFBI is an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. TGFBI plays a role in cell-collagen interactions and may be involved in endochondral bone formation in cartilage. TGFBI is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in TGFBI are associated with multiple types of corneal dys... | |||
TMPY-00117 |
FGF-16 Protein, Human, Cynomolgus, Recombinant
fibroblast growth factor 16 |
Human,Cynomolgus | Baculovirus Insect Cells |
Fibroblast growth factor 16 (FGF16) is preferentially expressed in the heart after birth, suggesting its regulation is associated with tissue-specific chromatin remodeling and DNA-protein interactions. Mutation of the MEF2 site resulted in a blunting of FGF16 promoter activity in transfected neonatal rat cardiac myocytes, that chromatin remodeling and MEF2 binding in the FGF16 promoter contribute to expression in the postnatal heart. FGF16 involvement in the fine tuning of the human skeleton of ... | |||
TMPJ-01204 |
TPSAB1 Protein, Human, Recombinant (His)
TPS1,tryptase alpha/beta 1,TPS2,tryptase α/β1,tryptase α/β 1... |
Human | HEK293 Cells |
Tryptases are serine proteases with trypsin-like specificity. Together with chymases and Cathepsin G, tryptases are important players in mast cell mediation of inflammatory and allergic responses. Tryptase alpha/beta-1(TPSAB1), also known as mast cell protease 7 (MCPT7), it exhibits anticoagulant activity due to its ability to degrade fibrinogen in the presence of a diverse array of protease inhibitors in plasma. The two Isoform 1 and isoform 2 are expressed in lung, stomach, spleen, heart and s... | |||
TMPK-00735 |
CXCL13/BCA-1 Protein, Mouse, Recombinant (His)
ANGIE,BLR1L,ANGIE2,BLC,SCYB13,BCA1,BCA-1 |
Mouse | HEK293 Cells |
Recent studies have implicated chemokines in microglial activation and pathogenesis of neuropathic pain. C-X-C motif chemokine 13 (CXCL13) is a B lymphocyte chemoattractant that activates CXCR5. Using the spinal nerve ligation (SNL) model of neuropathic pain, CXCL13 was persistently upregulated in spinal cord neurons after SNL, resulting in spinal astrocyte activation via CXCR5 in mice. CXCL13/BCA-1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with N-His tag. The pred... | |||
TMPY-05033 |
5T4/TPBG Protein, Human, Recombinant (aa 60-345, His)
5T4AG,trophoblast glycoprotein,WAIF1,M6P1,5T4 |
Human | HEK293 Cells |
Trophoblast glycoprotein (TPBG), also known as 5T4, is the therapeutic target of several anticancer agents currently in clinical development, largely due to its high expression in tumors and low expression in normal adult tissues. 5T4/TPBG Protein, Human, Recombinant (aa 60-345, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 33.1 kDa and the accession number is Q13641. | |||
TMPY-03956 |
Fas Ligand Protein, Human, Recombinant (His)
TNLG1A,FASL,FASLG,CD178,CD95-L,APT1LG1,APTL,CD95L,Fas ligand... |
Human | P. pastoris (Yeast) |
Fas Ligand, also known as FASLG and CD95L, is the ligand for FAS. It is a transmembrane protein which binds to TNFRSF6/FAS. Interaction of FAS with fas Ligand is critical in triggering apoptosis of some types of cells such as lymphocytes. Fas Ligand may be involved in cytotoxic T-cell mediated apoptosis and in T-cell development. TNFRSF6/FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. Fas Ligand Protei... | |||
TMPY-04722 |
DcR1/TRAILR3 Protein, Human, Recombinant (His)
TRAILR3,TRID,DCR1,TRAIL-R3,CD263,DCR1-TNFR,tumor necrosis fa... |
Human | HEK293 Cells |
TNFRSF10C CNV in patients with CRC is associated with distant metastatic disease. A high frequency of CGI methylation in the TNFRSF10C promoter results in inactivation of the gene and enhancement of tumor growth in most PC cell lines (except CFPAC-1). Inactivation of TNFRSF10C by CpG island (CGI) hypermethylation can play an important role in PC progression and be potentially useful as a diagnostic marker and a new therapeutic approach for PC. | |||
TMPY-01075 |
Von Willebrand Factor/vWF Protein, Human, Recombinant (His)
von Willebrand factor,VWD,F8VWF |
Human | CHO Cells |
Von Willebrand Factor (VWF) is a multimeric glycoprotein involved in hemostasis in blood, binds receptors on the surface of platelets and in connective tissue, thereby mediating the adhesion of platelets to sites of vascular injury. From studies it appears that VWF protein uncoils under these circumstances, decelerating passing platelets. VWF protein is deficient or defective in von Willebrand disease (VWD) and is involved in a large number of other diseases, including thrombosis, thrombotic thr... | |||
TMPY-03425 |
Tau Protein, Human, Recombinant (His)
PPND,FTDP-17,MTBT1,DDPAC,MAPTL,MTBT2,microtubule-associated ... |
Human | E. coli |
MAPT (microtubule-associated protein tau) can produce tau proteins. Tau proteins are proteins that stabilize microtubules. They are abundant in neurons of the central nervous system and are less common elsewhere, but are also expressed at very low levels in CNS astrocytes and oligodendrocytes. When tau proteins are defective, and no longer stabilize microtubules properly, they can result in dementias such as Alzheimer's disease. Tau protein is a highly soluble microtubule-associated protein (MAP... | |||
TMPY-00539 |
GSTA1 Protein, Human, Recombinant (His)
glutathione S-transferase alpha 1,GTH1,GST2,glutathione S-tr... |
Human | HEK293 Cells |
GSTA1 (Glutathione S-Transferase Alpha 1) is a Protein Coding gene. This gene encodes a member of a family of enzymes that function to add glutathione to target electrophilic compounds. Glutathione S-transferases (GSTs) are involved in the detoxification of carcinogens and may be linked to carcinogenesis. As a vital component of GSTs, GSTA1 plays an important role in carcinogenesis. GSTA1 expression may be a target molecule in the early diagnosis and treatment of lung cancer. Human colonic adeno... | |||
TMPY-00365 |
GALNT7 Protein, Human, Recombinant (His)
GalNAcT7,polypeptide N-acetylgalactosaminyltransfer... |
Human | HEK293 Cells |
GalNAc-transferase-7 (GALNT7) is essential for the regulation of cell proliferation and has been implicated in tumorigenesis. Colorectal cancer (CRC) arises in a multistep molecular network process, which is from either discrete genetic perturbation or epigenetic dysregulation. GALNT7 acts as a glycosyltransferase in protein O-glycosylation, involving in the occurrence and development of CRC. GALNT7 silencing significantly attenuated the proliferation, clonogenicity and migration of LSCC cells a... | |||
TMPK-00369 |
HGF Protein, Human, Recombinant (hFc)
HGF,F-TCF,HGFB,SF,F-TCFB,肝细胞生长因子,DFNB39,Hepatopoietin |
Human | HEK293 Cells |
Hepatocyte growth factor (HGF) is an important component of the pathophysiology of IR, with increased levels in most common IR conditions, including obesity. HGF has a role in the metabolic flux of glucose in different insulin sensitive cell types; plays a key role in β-cell homeostasis; and is capable of modulating the inflammatory response.HGF plays a central role in these metabolic disorders,HGF levels could be employed as a biomarker for disease status/progression, and HGF/c-Met signaling pa... | |||
TMPK-01074 |
CD163 Protein, Human, Recombinant (His & Avi)
CD163,HbSR,RM3/1,MM130,CD163 molecule,GHI/61,sCD163,SCARI1,M... |
Human | HEK293 Cells |
The hemoglobin (Hb) scavenger receptor, CD163, is a macrophage-specific protein and the upregulated expression of this receptor is one of the major changes in the macrophage switch to alternative activated phenotypes in inflammation. Accordingly, a high CD163 expression in macrophages is a characteristic of tissues responding to inflammation. CD163 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 111.4 kDa and th... | |||
TMPY-05030 |
PCDH7 Protein, Human, Recombinant (His)
BHPCDH |
Human | Baculovirus Insect Cells |
PCDH7, a member of protocadherins family, functions as tumor suppressor in several human cancers. The human PCDH7 gene is localized in chromosome 4p15, which is often inactivated in human cancers, including bladder cancer. The low PCDH7 expression is a potential prognostic biomarker for primary non-muscle invasive bladder cancer (NMIBC). PCDH7 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 94 kDa and the accession number... | |||
TMPY-02956 |
Apolipoprotein L/APOL1 Protein, Human, Recombinant (His)
APOL1,apolipoprotein L1,APOL,FSGS4,APOL-I,APO-L |
Human | Baculovirus Insect Cells |
APOL1, also known as apolipoprotein L1, is a minor apoprotein component of HDL (High-density lipoprotein) or 'good cholesterol' which is synthesized in the liver and also in many other tissues, including pancreas, kidney, and brain. APOL1 belongs to the apolipoprotein L family. It may play a role in lipid exchange and transport throughout the body. It may also participate in reverse cholesterol transport from peripheral cells to the liver. Defects in APOL1 are the cause of focal segmental glomer... | |||
TMPY-05558 |
Recombinant Protein L, PE conjugated
|
E. coli | |
Recombinant Protein L, PE conjugated is expressed in E. coli expression system. | |||
TMPY-00021 |
PADI4 Protein, Human, Recombinant (His)
PADI5,PAD4,PDI4,peptidyl arginine deim... |
Human | Baculovirus Insect Cells |
Protein-arginine deiminase type-4, also known as HL-6 PAD, Peptidylarginine deiminase IV, Protein-arginine deiminase type I V and PADI4, is a cytoplasm and nucleus protein that belongs to the protein arginine deiminase family. PADI4 is expressed in CD34+stem cells in normal tissues, and many more CD34+ cells expressing PADI4 are present in tumour tissues. PADI4 post-translationally converts peptidylarginine to citrulline, a process called citrullination. Studies have demonstrated the high expres... | |||
TMPJ-00249 |
TGF beta 1 Protein, Human, Recombinant (Avi), Biotinylated
TGF-Beta-1,TGFB1,Transforming Growth Factor β-1,Lat... |
Human | HEK293 Cells |
Transforming Growth Factor β-1 (TGFβ-1) is a secreted protein which belongs to the TGF-β family. TGFβ-1 is abundantly expressed in bone, articular cartilage and chondrocytes and is increased in osteoarthritis (OA). TGFβ-1 performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis. The precursor is cleaved into a latency-associated peptide (LAP) and a mature TGFβ-1 peptide. TGFβ-1 may also form heterodimers with other TGFβ family... | |||
------------------------ 更多 ------------------------ |